Silexion Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLXN and other ETFs, options, and stocks.About SLXN
Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
CEOIlan Hadar
CEOIlan Hadar
Employees14
Employees14
HeadquartersRamat-Gan, Tel Aviv
HeadquartersRamat-Gan, Tel Aviv
Founded2008
Founded2008
Employees14
Employees14
SLXN Key Statistics
Market cap6.72M
Market cap6.72M
Price-Earnings ratio-0.09
Price-Earnings ratio-0.09
Dividend yield—
Dividend yield—
Average volume51.13K
Average volume51.13K
High today—
High today—
Low today—
Low today—
Open price$2.21
Open price$2.21
Volume0.00
Volume0.00
52 Week high$51.75
52 Week high$51.75
52 Week low$1.65
52 Week low$1.65
Stock Snapshot
As of today, Silexion Therapeutics(SLXN) shares are valued at $2.14. The company's market cap stands at 6.72M, with a P/E ratio of -0.09.
During the trading day, Silexion Therapeutics(SLXN) stock saw an opening price of $2.21, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 51.13K.
The stock's 52-week range extends from a low of $1.65 to a high of $51.75.
The stock's 52-week range extends from a low of $1.65 to a high of $51.75.
People also own
Based on the portfolios of people who own SLXN. This list is generated using Robinhood data, and it’s not a recommendation.